The increased expression levels of LMNB1 can enhance cell migration potential, which may contribute to the progression and metastasis of some cancers [42, 43], including pancreatic cancer (PC), prostate cancer, lung cancer, hepatocellular carcinoma (HCC), and kidney cancer. Here, LMNB1 is linked to pachyonychia congenita.